Nanotechnology World Conference 2026
The Nanotechnology World Conference (NTWC 2026) will be held on October 18-20, 2026 at Bangkok, Thailand. This year, the conference
Cyclodextrins open way for aqueous extraction of phlorotannins producing extracts with improved stability during gastrointestinal transit
Phlorotannins have gained significant attention as functional supplements because of their potential bioactive and functional properties. Phlorotannins are, however, highly
Obituary for Prof. Dr.-Ing. Wolfram Saenger
Prof. Dr.-Ing. Wolfram Saenger passed away on 16 February 2026. He was a German biochemist and protein scientist renowned for
Toxic effects and cellular uptake of functional polyrotaxanes. The little we have learned and the many unknowns still waiting to be discovered.
Cyclodextrins are commonly used as excipients in modern drug delivery, but they also have a less common role as active
Oral Treatment of Obesity by GLP-1 and Its Analogs
Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics
Special issue: Advanced Polymeric Biomaterials for Drug Delivery Applications
The present Special Issue in Polymers welcomes contributions in the form of original research articles, preclinical investigations, or review articles
On-off switch of cellular migration using granular hydrogels containing beta-CD and adamantane
Cell migration plays a crucial role in the dynamic processes that guide tissue development, regeneration, and repair; yet, developing cell
Nitric Oxide-Releasing Thixotropic Hydrogels as Antibacterial and Hemocompatible Catheter Locks
Catheter locks are used to prevent infection and clotting in indwelling catheters, but most current locks are simple liquids. These
delta-Cyclodextrin is commercially available at Biosynth
δ‑Cyclodextrin (δ‑CD or delta-CD) is a unique, novel nine-membered cyclodextrin with a larger internal cavity than α-, β-, or γ-cyclodextrins,
Beren Therapeutics’Adrabetadex Received FDA Acceptance for infantile-onset Niemann Pick Disease
Beren Therapeutics Announced FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann-Pick Disease Type C. Beren Therapeutics
5th International Conference Integrative Chemistry, Biology & Translational Medicine
The conference will be held on 25-27 June 2026 in Debrecen. The journey of ICBTM began in 2019 with the